Aditxt, Inc. filings document the company’s life sciences platform, its common stock capital structure, and material events affecting its operating subsidiaries and public-company status. Recent Form 8-K reports cover the completed acquisition of Ignite Proteomics, related financial statements and pro forma information, senior unsecured promissory notes, at-the-market offering capacity, and Nasdaq listing-compliance matters.
Proxy materials and meeting reports describe board elections, auditor ratification, executive-compensation votes, reverse stock split authority, and other stockholder matters. The filing record also includes disclosures on preferred stock issued in acquisition consideration, equity financing arrangements, governance approvals, and risks associated with maintaining exchange listing standards.
Aditxt, Inc. expanded its senior secured convertible note financing to an aggregate original principal amount of $6,254,355.17 under an amended note purchase agreement with investors.
The company and its subsidiary Ignite Proteomics LLC issued an additional $769,230.77 in original principal amount of notes for a cash purchase price of $500,000.00, secured by substantially all Ignite assets and a pledge of Aditxt’s equity in Ignite.
The additional notes were sold as unregistered securities under Section 4(a)(2) and Rule 506(b) of Regulation D, and Aditxt had 997,976,543 common shares outstanding as of June 22, 2026.
Takeover Time 2026 LLC has filed an initial ownership report for Aditxt, Inc., stating a direct holding of Aditxt common stock. The filing shows that the entity is a ten percent owner and reports ownership of 3,420,439 shares of common stock following the reported position. This Form 3 is an initial statement of beneficial ownership and does not reflect a new purchase or sale but rather discloses an existing stake.
Takeover Time 2026 LLC filed a Schedule 13D reporting a significant equity position in Aditxt, Inc. (ADTX). The firm beneficially owns 3,420,439 shares of common stock, which it estimates to represent 10.9% of the class based on the best information currently available.
The reporting person states it acquired the shares on June 12, 2026 for investment purposes using its working capital, paying an aggregate purchase price of approximately $50,000, excluding commissions and other costs. It currently has no plans or proposals to change or influence control of Aditxt, but may buy or sell shares or engage with the company in the future depending on market conditions and other factors. Takeover Time 2026 LLC reports sole voting and dispositive power over all 3,420,439 shares and notes the actual ownership percentage may be higher, as the issuer’s most recently disclosed share count appears stale.
Aditxt, Inc. reports a Schedule 13G filing showing Jonathan Edward Hester beneficially owns 81,592 shares of Common Stock (06/15/2026), representing 9.9% of the class as reported. The filing notes the position equals approximately 9.9999% of outstanding shares and clarifies the 9.9% figure reflects EDGAR rounding.
Aditxt, Inc. filed an Amendment No. 1 to a Schedule 13G/A disclosing that Justin Ching-Johnson reports 0 shares of Common Stock, representing 0% ownership of the class. The filing lists the issuer address and CUSIP 007025869.
Aditxt, Inc. reports a Schedule 13G showing Justin Ching-Johnson beneficially owns 80,100 shares of Common Stock. The filing lists 80,100 shares, representing 9.8% of the class, with sole voting and dispositive power. The filing gives the reporting person's address in Nova Scotia and is signed 06/18/2026.
HRT Financial LP, a ten percent owner of Aditxt, Inc. (ADTX), reported an open-market sale of 3,132,480 Class A Shares at $0.013 per share. After this transaction on June 16, 2026, the filing shows HRT Financial LP holding 0 Class A Shares directly.
Jeongho Lee reported beneficial ownership of 66,666 shares of Aditxt, Inc. common stock. The filing states Mr. Lee has sole voting and dispositive power over 66,666 shares, representing 8.2% of the class. The signature date is 06/18/2026.
The filing lists the issuer address as 737 N. Fifth Street, Richmond, Virginia, and the filer address as 415 - 50 Holly Street, Toronto, Ontario.
DRW Securities, LLC, a 10% owner of Aditxt, Inc., sold 126,772 shares of Aditxt common stock in an open-market transaction at $0.0079 per share. After this sale, the filing shows DRW Securities with zero shares of Aditxt common stock reported as directly owned.
Aditxt, Inc. reported an insider transaction by major shareholder HRT Financial LP. On June 15, 2026, HRT Financial LP executed an open-market purchase of 2,114,344 shares of Aditxt common stock at $0.014 per share. Following this transaction, HRT Financial LP directly holds 344,964 shares of Aditxt common stock according to the filing. This activity was disclosed on a Form 4 as a transaction by a ten percent owner.